API China is China's leading exhibition for the pharmaceutical manufacturing sector covering the complete spectrum of products from raw materials, fine chemicals, intermediates, ingredients, processing machinery and packaging machinery. It is a must-see event for international buyers to meet Asian sellers, most particularly Chinese ingredients manufacturers.
In the first quarter of 2016, the total value of China’s imports and exports of medicines and health products is 23.667 billion dollars
The organizer posted a record 380,000 entry scans, 216,784 professional visitors and more than 55,000 exhibiting staff to the venue over four days.
CFDA released the reform plan for chemical drug registration classification. The reform plan came into force from the date of promulgation.
the Session on Drug Review and Approval, with the theme of "cracking down on counterfeiting, improving drug quality, promoting drug review and approval system reform & drug innovation"